Regulation of HIF: prolyl hydroxylases.

Regulation of HIF: prolyl hydroxylases.

Hypoxia inducible factor (HIF) is an alpha/beta heterodimeric transcriptional complex that plays a key role in directing cellular responses to hypoxia. Recent studies have defined novel oxygen-sensitive signal pathways that regulate the activity of HIF by post-translational hydroxylation at specific...

書誌詳細
主要な著者:	Stolze, I, Mole, D, Ratcliffe, P
フォーマット:	Journal article
言語:	English
出版事項:	2006

類似資料

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
著者:: Mole, D, 等
出版事項: (2003)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
著者:: Tuckerman, JR, 等
出版事項: (2004)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
著者:: Schlemminger, I, 等
出版事項: (2003)

Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation.
著者:: Tian, Y, 等
出版事項: (2006)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
著者:: Chan, M, 等
出版事項: (2016)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
著者:: McNeill, L, 等
出版事項: (2002)

HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
著者:: Masson, N, 等
出版事項: (2003)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
著者:: Cockman, M, 等
出版事項: (2019)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
著者:: Matthew E Cockman, 等
出版事項: (2019-09-01)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
著者:: Chowdhury, R, 等
出版事項: (2016)

Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
著者:: Yeoh, K, 等
出版事項: (2013)

Iron homeostasis and its interaction with prolyl hydroxylases.
著者:: Mole, D
出版事項: (2010)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
著者:: Rasheduzzaman Chowdhury, 等
出版事項: (2016-08-01)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
著者:: Yeh, TL, 等
出版事項: (2017)

The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin.
著者:: Masson, N, 等
出版事項: (2004)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
著者:: Chowdhury, R, 等
出版事項: (2013)

Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses
著者:: Moritz J. Strowitzki, 等
出版事項: (2021-04-01)

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
著者:: Andrey A. Poloznikov, 等
出版事項: (2021-01-01)

Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes
著者:: Wijeyekoon, JB
出版事項: (2013)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
著者:: Maria Savyuk, 等
出版事項: (2020-07-01)

HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation.
著者:: Willam, C, 等
出版事項: (2006)

The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity.
著者:: Foxler, D, 等
出版事項: (2012)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
著者:: Holt-Martyn, JP, 等
出版事項: (2019)

Oxygen sensing by HIF hydroxylases.
著者:: Schofield, C, 等
出版事項: (2004)

Signalling hypoxia by HIF hydroxylases.
著者:: Schofield, C, 等
出版事項: (2005)

Structural, biochemical and inhibition studies on hypoxia-inducible factor (HIF) prolyl hydroxylases
著者:: Lippl, K
出版事項: (2018)

Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
著者:: Takahiro Kambara, 等
出版事項: (2024-03-01)

HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
著者:: Kiichi Hirota
出版事項: (2021-04-01)

The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer
著者:: Kilian B. Kennel, 等
出版事項: (2022-11-01)

Network activity in primary hippocampal cultures upon HIF-prolyl hydroxylase inhibition
著者:: Savyuk, Maria Olegovna, 等
出版事項: (2021-05-01)

Inhibition of HIF-prolyl 4-hydroxylases as a promising approach to the therapy of cardiometabolic diseases
著者:: K A Aitbaev, 等
出版事項: (2018-08-01)

The HIF hydroxylase pathway and the tumour microenvironment
著者:: Ratcliffe, P
出版事項: (2008)

Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility.
著者:: Astuti, D, 等
出版事項: (2011)

Prolyl hydroxylases and therapeutics.
著者:: Smith, T, 等
出版事項: (2010)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.
著者:: Chen, R, 等
出版事項: (2014)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice
著者:: Chen, R, 等
出版事項: (2014)

No benefit of HIF prolyl hydroxylase inhibition for hypertensive renal damage in renovascular hypertensive rats
著者:: Andrea Hartner, 等
出版事項: (2023-06-01)

Mutation Analysis of HIF-prolyl hydroxylases (PHD/EGLN) in Inherited Phaeochromocytoma and Renal Cell Carcinoma
著者:: Astuti, D, 等
出版事項: (2010)

Epigenetic regulators of neuronal ferroptosis identify novel therapeutics for neurological diseases: HDACs, transglutaminases, and HIF prolyl hydroxylases
著者:: Orjon Rroji, 等
出版事項: (2021-01-01)

Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
著者:: Hewitson, K, 等
出版事項: (2007)